Drug profile · INN
almotriptan malate
ALMOTRIPTAN MALATE
almotriptan malate (ALMOTRIPTAN MALATE) is a serotonin 1f (5-ht1f) receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — almotriptan malate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
almotriptan malate (ALMOTRIPTAN MALATE) is a serotonin 1f (5-ht1f) receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 1f (5-HT1f) receptor agonist
Primary target: 5-hydroxytryptamine receptor 1B
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is almotriptan malate?
almotriptan malate (ALMOTRIPTAN MALATE) is a serotonin 1f (5-ht1f) receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for almotriptan malate?
ALMOTRIPTAN MALATE is a marketed brand name for almotriptan malate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of almotriptan malate?
almotriptan malate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.